Immunotherapy Foundation (IF) was established in 2015 to support cutting-edge immunotherapy research at Moores Cancer Center at the University of California, San Diego (UCSD) and the La Jolla Institute for Allergy and Immunology (LIAI). This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs. IF’s initial mission is to find an effective treatment - and ultimately a cure - for HPV-related cancers. IF is recognized by the IRS as a public nonprofit organization under section 501(c)(3) of the Internal Revenue Code.